ISLAND PHARMACEUTICALS LTD宣布,美国食品药品监督管理局(FDA)已批准在其药物加利昔韦的开放性试验性新药申请框架下召开C类会议。
ISLAND PHARMACEUTICALS LTD宣布,美国食品药品监督管理局(FDA)已批准在其药物加利昔韦的开放性试验性新药申请框架下召开C类会议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.